$ALT
Altimmune Inc

2022 Q4 Form 10-Q Financial Statement

#000132619022000013 Filed on November 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue -$68.00K $2.000K $157.6K
YoY Change -102.07% -98.73% -94.64%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $17.13M $4.492M $4.156M
YoY Change 353.61% 8.09% -1.52%
% of Gross Profit
Research & Development $70.54M $20.26M $29.21M
YoY Change 249.46% -30.62% 71.38%
% of Gross Profit
Depreciation & Amortization -$141.0K $100.0K
YoY Change -241.0% 0.0%
% of Gross Profit
Operating Expenses $87.67M $24.75M $33.36M
YoY Change 265.87% -25.8% 56.91%
Operating Profit -$24.75M -$33.20M
YoY Change -25.46% 81.2%
Interest Expense $2.862M $64.00K $32.87K
YoY Change 1526.14% 94.73% 1344.66%
% of Operating Profit
Other Income/Expense, Net -$32.00K $1.039M -$306.6K
YoY Change -60.32% -438.9% -525.39%
Pretax Income -$84.91M -$23.71M -$33.51M
YoY Change 255.43% -29.24% 83.6%
Income Tax -$197.0K -$200.0K $0.00
% Of Pretax Income
Net Earnings -$84.71M -$23.52M -$33.51M
YoY Change 254.61% -29.83% 88.58%
Net Earnings / Revenue -1175800.0% -21268.66%
Basic Earnings Per Share -$0.48 -$0.81
Diluted Earnings Per Share -$1.81 -$0.48 -$0.81
COMMON SHARES
Basic Shares Outstanding 49.16M 48.54M 39.71M
Diluted Shares Outstanding 49.29M 41.37M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $184.9M $201.8M $199.9M
YoY Change -2.85% 0.97% -3.34%
Cash & Equivalents $111.1M $127.5M $174.9M
Short-Term Investments $73.78M $74.36M $25.02M
Other Short-Term Assets $5.392M $4.824M $7.329M
YoY Change -32.49% -34.18% 463.73%
Inventory
Prepaid Expenses
Receivables $173.0K $633.0K $1.574M
Other Receivables $2.368M $3.720M $9.476M
Total Short-Term Assets $192.8M $211.0M $218.3M
YoY Change -5.54% -3.33% 0.06%
LONG-TERM ASSETS
Property, Plant & Equipment $1.081M $1.172M $4.718M
YoY Change -25.35% -75.16% 352.83%
Goodwill
YoY Change
Intangibles $12.42M $12.42M $12.99M
YoY Change 0.0% -4.42% 1.55%
Long-Term Investments
YoY Change
Other Assets $615.0K $682.0K $931.9K
YoY Change -29.47% -26.82% 968.76%
Total Long-Term Assets $14.12M $14.27M $18.64M
YoY Change -4.23% -23.44% 25.43%
TOTAL ASSETS
Total Short-Term Assets $192.8M $211.0M $218.3M
Total Long-Term Assets $14.12M $14.27M $18.64M
Total Assets $206.9M $225.3M $236.9M
YoY Change -5.45% -4.91% 1.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.804M $1.419M $6.083K
YoY Change 136.18% 23227.31% -99.3%
Accrued Expenses $11.08M $13.15M $19.12M
YoY Change 9.16% -31.21% 252.86%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $17.05M $15.74M $19.13M
YoY Change -6.69% -17.7% 203.91%
LONG-TERM LIABILITIES
Long-Term Debt $4.581M $4.506M $1.566M
YoY Change 215.06% 187.81% -18.7%
Other Long-Term Liabilities $60.00K $66.00K $85.49K
YoY Change -25.0% -22.8% -25.84%
Total Long-Term Liabilities $4.641M $4.572M $1.651M
YoY Change 202.54% 176.91% -19.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.05M $15.74M $19.13M
Total Long-Term Liabilities $4.641M $4.572M $1.651M
Total Liabilities $21.64M $20.25M $27.64M
YoY Change 9.66% -26.75% -16.96%
SHAREHOLDERS EQUITY
Retained Earnings -$377.9M -$356.2M -$269.3M
YoY Change 28.9% 32.29% 53.18%
Common Stock $5.000K $5.000K $3.959K
YoY Change 25.0% 26.29% 20.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $185.3M $205.0M $209.3M
YoY Change
Total Liabilities & Shareholders Equity $206.9M $225.3M $236.9M
YoY Change -5.45% -4.91% 1.68%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$84.71M -$23.52M -$33.51M
YoY Change 254.61% -29.83% 88.58%
Depreciation, Depletion And Amortization -$141.0K $100.0K
YoY Change -241.0% 0.0%
Cash From Operating Activities -$17.31M -$15.05M -$17.78M
YoY Change -21.22% -15.33% 87.11%
INVESTING ACTIVITIES
Capital Expenditures $38.00K -$60.00K -$114.1K
YoY Change -125.03% -47.41% 42.61%
Acquisitions
YoY Change
Other Investing Activities $1.019M -$25.34M $18.53M
YoY Change -95.93% -236.8% -138.75%
Cash From Investing Activities $981.0K -$25.40M $18.41M
YoY Change -96.06% -237.97% -138.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -43.00K 32.06M 124.4K
YoY Change -100.34% 25663.42% -99.91%
NET CHANGE
Cash From Operating Activities -17.31M -15.05M -17.78M
Cash From Investing Activities 981.0K -25.40M 18.41M
Cash From Financing Activities -43.00K 32.06M 124.4K
Net Change In Cash -16.37M -8.393M 761.2K
YoY Change -206.03% -1202.63% -99.03%
FREE CASH FLOW
Cash From Operating Activities -$17.31M -$15.05M -$17.78M
Capital Expenditures $38.00K -$60.00K -$114.1K
Free Cash Flow -$17.34M -$14.99M -$17.66M
YoY Change -20.5% -15.12% 87.49%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49286535
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41370768
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45881547
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40843905
dei Entity Central Index Key
EntityCentralIndexKey
0001326190
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49161637
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40993768
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.81
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.37
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.79
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-32587
dei Entity Registrant Name
EntityRegistrantName
ALTIMMUNE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-2726770
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
127465000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
190301000
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
34000
dei Entity Address Address Line1
EntityAddressAddressLine1
910 Clopper Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 201S
dei Entity Address City Or Town
EntityAddressCityOrTown
Gaithersburg
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20878
dei City Area Code
CityAreaCode
240
dei Local Phone Number
LocalPhoneNumber
654-1450
dei Security12b Title
Security12bTitle
Common stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
ALT
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49159056
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
34000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
127499000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
190335000
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
74362000
CY2022Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
633000
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
429000
CY2022Q3 alt Income Taxes And Research Development Incentive Receivable Current
IncomeTaxesAndResearchDevelopmentIncentiveReceivableCurrent
3720000
CY2021Q4 alt Income Taxes And Research Development Incentive Receivable Current
IncomeTaxesAndResearchDevelopmentIncentiveReceivableCurrent
5410000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4790000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7952000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
211004000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
204126000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1172000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1448000
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12419000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12419000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
682000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
872000
CY2022Q3 us-gaap Assets
Assets
225277000
CY2021Q4 us-gaap Assets
Assets
218865000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1419000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2034000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
6090000
CY2022Q3 alt Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
14323000
CY2021Q4 alt Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
10152000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
15742000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18276000
CY2022Q3 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
4506000
CY2021Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
1454000
CY2022Q3 us-gaap Liabilities
Liabilities
20248000
CY2021Q4 us-gaap Liabilities
Liabilities
19730000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49161637
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40993768
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
5000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
566551000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
497342000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-356224000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-293171000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5303000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5040000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
205029000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
199135000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
225277000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
218865000
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1053000
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
13000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1402000
us-gaap Investment Income Interest
InvestmentIncomeInterest
88000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
158000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45881547
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
50000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-286000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
42000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1133000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20262000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29206000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
51359000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
54356000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4492000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4156000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13329000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11636000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
8070000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
24754000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
33362000
us-gaap Operating Expenses
OperatingExpenses
64688000
us-gaap Operating Expenses
OperatingExpenses
74062000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-24752000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-33204000
us-gaap Operating Income Loss
OperatingIncomeLoss
-64646000
us-gaap Operating Income Loss
OperatingIncomeLoss
-72929000
CY2022Q3 us-gaap Interest Expense
InterestExpense
64000
CY2021Q3 us-gaap Interest Expense
InterestExpense
33000
us-gaap Interest Expense
InterestExpense
191000
us-gaap Interest Expense
InterestExpense
67000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
185000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-293000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1039000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-306000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1396000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-272000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23713000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-33510000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-63250000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-73201000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-197000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-197000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-23516000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-33510000
us-gaap Net Income Loss
NetIncomeLoss
-63053000
us-gaap Net Income Loss
NetIncomeLoss
-73201000
CY2022Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-143000
CY2021Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-2000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-263000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
4000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40843905
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-23659000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-33512000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-63316000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-73197000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.81
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.37
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.79
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
199135000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49286535
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41370768
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2033000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
197000
CY2022Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-170000
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
113000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1560000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
8070000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2990000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-19430000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
184868000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2048000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
403000
CY2022Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-80000
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
21347000
CY2022Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
6176000
CY2022Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-120000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-20107000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
194535000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2128000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
268000
CY2022Q3 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-140000
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
31829000
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
68000
CY2022Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-143000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-23516000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
205029000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
225876000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1218000
CY2021Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-92000
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
106000
CY2021Q1 alt Retirement Of Common Sock In Exchange For Common Stock Warrant
RetirementOfCommonSockInExchangeForCommonStockWarrant
-17200000
CY2021Q1 alt Issuance Of Common Stock Warrant In Exchange For Retirement Of Common Stock
IssuanceOfCommonStockWarrantInExchangeForRetirementOfCommonStock
17200000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
34178000
CY2021Q1 alt Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
10000
CY2021Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
5000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-14864000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
246437000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1485000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
94000
CY2021Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-90000
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
18178000
CY2021Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-24827000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
241278000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1497000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6000
CY2021Q3 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-124000
CY2021Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
119000
CY2021Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-2000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-33510000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
209264000
us-gaap Profit Loss
ProfitLoss
-63053000
us-gaap Profit Loss
ProfitLoss
-73201000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
86000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
31000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
52563000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
434000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
225000
us-gaap Share Based Compensation
ShareBasedCompensation
6209000
us-gaap Share Based Compensation
ShareBasedCompensation
4200000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
477000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
100000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
56824000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
183000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-297000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
204000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3036000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3204000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5263000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-615000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-606000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
7555000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
6916000
alt Increase Decrease In Income Taxes And Tax Incentive Receivable
IncreaseDecreaseInIncomeTaxesAndTaxIncentiveReceivable
-1690000
alt Increase Decrease In Income Taxes And Tax Incentive Receivable
IncreaseDecreaseInIncomeTaxesAndTaxIncentiveReceivable
1714000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-45280000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-56271000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
82406000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
74292000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
7592000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
88000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11970000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
190000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-74380000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
62654000
alt Payments Of Deferred Offering Costs
PaymentsOfDeferredOfferingCosts
118000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
56166000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
52356000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
181000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-62836000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
58946000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
190335000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
115952000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
127499000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
174898000
alt Common Stock Issued Related To Contingent Consideration Liability
CommonStockIssuedRelatedToContingentConsiderationLiability
6176000
alt Addition Operating Lease Liability And Right Of Use Asset
AdditionOperatingLeaseLiabilityAndRightOfUseAsset
72000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The preparation of these financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The extent to which the COVID-19 pandemic, including any resurgences or the emergence of new variants, may directly or indirectly impact the Company’s business, financial condition, and results of operations is highly uncertain and subject to change. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company considered the potential impact of the COVID-19 pandemic on the Company’s estimates and assumptions and determined that there was not a material impact to the Company’s unaudited consolidated financial statements as of and for the three and nine months ended September 30, 2022. However, actual results could differ from those estimates and there may be changes to the Company’s estimates in future periods.</p>
CY2022Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
74625000
CY2022Q3 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
-263000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
74362000
CY2022Q3 alt Assets Or Liabilities Measured At Fair Value On Non Recurring Basis
AssetsOrLiabilitiesMeasuredAtFairValueOnNonRecurringBasis
0
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
100000
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
100000
us-gaap Operating Lease Expense
OperatingLeaseExpense
400000
us-gaap Operating Lease Expense
OperatingLeaseExpense
400000
us-gaap Operating Lease Payments
OperatingLeasePayments
400000
us-gaap Operating Lease Payments
OperatingLeasePayments
400000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1230000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1535000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
649000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
798000
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M6D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y3M18D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.072
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.072
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
624000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
396000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2110000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2313000
CY2022Q3 alt Accrued Research And Development
AccruedResearchAndDevelopment
9930000
CY2021Q4 alt Accrued Research And Development
AccruedResearchAndDevelopment
6988000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
442000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
411000
CY2022Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1169000
CY2022Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
48000
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
44000
CY2022Q3 alt Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
14323000
CY2021Q4 alt Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
10152000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
6090000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
5390000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
86000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1560000
us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
6176000
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
6950000
alt Research And Development Incentive Credit Earned
ResearchAndDevelopmentIncentiveCreditEarned
3400000
CY2022Q3 alt Research And Development Incentive Credit
ResearchAndDevelopmentIncentiveCredit
3402000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
788000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1124000
CY2022Q3 alt Economic Conditional Incentive Grants
EconomicConditionalIncentiveGrants
250000
CY2021Q4 alt Economic Conditional Incentive Grants
EconomicConditionalIncentiveGrants
250000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
66000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
80000
CY2022Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4506000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1454000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2128000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1497000
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2776191
alt Warrants Expired
WarrantsExpired
155
alt Number Of Warrants Exercised For Conversion Of Securities
NumberOfWarrantsExercisedForConversionOfSecurities
1760870
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1015166
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.66
CY2022Q3 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P1Y2M12D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3528473
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.09
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y10M24D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
16975
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1382587
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.75
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y9M18D
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
7824
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
2145886
alt Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedOutstandingWeightedAverageExercisePrice
9.31
alt Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedOutstandingWeightedAverageRemainingContractualTerm
P6Y
CY2022Q3 alt Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOutstandingIntrinsicValue
9151
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6209000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4200000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-200000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-200000
us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
0
CY2021Q3 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
0
us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
0
CY2022Q3 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
0

Files In Submission

Name View Source Status
0001326190-22-000013-index-headers.html Edgar Link pending
0001326190-22-000013-index.html Edgar Link pending
0001326190-22-000013.txt Edgar Link pending
0001326190-22-000013-xbrl.zip Edgar Link pending
alt-20220930.xsd Edgar Link pending
alt-20220930x10q.htm Edgar Link pending
alt-20220930x10q002.jpg Edgar Link pending
alt-20220930xex31d1.htm Edgar Link pending
alt-20220930xex31d2.htm Edgar Link pending
alt-20220930xex32d1.htm Edgar Link pending
alt-20220930xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
alt-20220930_cal.xml Edgar Link unprocessable
alt-20220930_def.xml Edgar Link unprocessable
alt-20220930_lab.xml Edgar Link unprocessable
alt-20220930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
alt-20220930x10q_htm.xml Edgar Link completed
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending